S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Options Trading Plan–Perfect For Beginners (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
The gold catalyst we've waited for (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
The gold catalyst we've waited for (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Options Trading Plan–Perfect For Beginners (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
The gold catalyst we've waited for (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
The gold catalyst we've waited for (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Options Trading Plan–Perfect For Beginners (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
The gold catalyst we've waited for (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
The gold catalyst we've waited for (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Options Trading Plan–Perfect For Beginners (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
The gold catalyst we've waited for (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
The gold catalyst we've waited for (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
OTCMKTS:BCYP

Big Cypress Acquisition (BCYP) Stock Forecast, Price & News

$8.44
-2.01 (-19.23%)
(As of 10/22/2021)
Compare
Today's Range
$8.21
▼
$12.90
50-Day Range
$8.44
▼
$8.44
52-Week Range
$8.21
▼
$12.90
Volume
15.34 million shs
Average Volume
160,982 shs
Market Capitalization
$124.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlines

BCYP stock logo

About Big Cypress Acquisition (OTCMKTS:BCYP) Stock

Big Cypress Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It primarily focuses in the life science sector. The company was incorporated in 2020 and is based in Miami Beach, Florida.

BCYP Price History

BCYP Stock News Headlines

September 21, 2023 | americanbankingnews.com
Big Cypress Acquisition (OTCMKTS:BCYP) Share Price Passes Above Fifty Day Moving Average of $8.44
September 10, 2023 | usatoday.com
Big 12 college football conference preview: Oklahoma, Texas ready to ride off into sunset
September 26, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
August 18, 2023 | finance.yahoo.com
Big Ridge Gold Completes Acquisition of Gold Island Inc. Creating a Premier Newfoundland Based Exploration Company
April 4, 2023 | forbes.com
Big Ass Fans
March 2, 2022 | reuters.com
SAB Biotherapeutics Inc
October 21, 2021 | finance.yahoo.com
Big Cypress Acquisition Corp. Stockholders Approve Business Combination with SAB Biotherapeutics
October 4, 2021 | finance.yahoo.com
SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19
September 26, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
September 28, 2021 | finance.yahoo.com
SAB Biotherapeutics Appoints Russell Beyer Chief Financial Officer
September 24, 2021 | finance.yahoo.com
SAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19
September 22, 2021 | finance.yahoo.com
SAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19
September 15, 2021 | finance.yahoo.com
SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza
September 8, 2021 | finance.yahoo.com
SAB Biotherapeutics to Present at Upcoming September Virtual Investor Conferences
August 11, 2021 | barrons.com
Big Cypress Acquisition Corp.
August 11, 2021 | finance.yahoo.com
SAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 Variants
August 10, 2021 | nasdaq.com
Big Cypress Acquisition Corp. Common stock (BCYP)
July 15, 2021 | in.finance.yahoo.com
STMP Jul 2021 300.000 put
July 15, 2021 | finance.yahoo.com
Big Cypress Acquisition Corp. Reports Ladenburg Conference Presentation by Planned Merger Partner SAB Biotherapeutics
July 10, 2021 | finance.yahoo.com
Lifshitz Law Firm, P.C. Announces Investigation of ALTA, BCYP, IKNX and STMP
July 7, 2021 | finance.yahoo.com
Big Cypress Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination with SAB Biotherapeutics
June 28, 2021 | finance.yahoo.com
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: CITIC Capital Acquisition Corp. (NYSE - CCAC), Thimble Point Acquisition Corp. (Nasdaq - THMA), Big Cypress Acquisition Corp. (Nasdaq - BCYP)
June 25, 2021 | apnews.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Big Cypress Acquisition Corp.
June 25, 2021 | feeds.benzinga.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Big Cypress Acquisition Corp. Merger
June 22, 2021 | finance.yahoo.com
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Big Cypress Acquisition Corp. (Nasdaq - BCYP)
June 22, 2021 | finance.yahoo.com
SAB Biotherapeutics to List on Nasdaq through Merger with Big Cypress Acquisition Corp., Advancing Unique Human Antibody Platform with Demonstrated Utility in Immunotherapy and Rapid Response to Emerging Diseases
June 11, 2021 | investing.com
Big Cypress Acquisition Corp (BCYP)
See More Headlines
Receive BCYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Big Cypress Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BCYP Company Calendar

Last Earnings
11/11/2014
Today
9/25/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BCYP
CUSIP
N/A
CIK
1399587
Web
www.bluecalypso.com
Phone
305-204-3338
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.13
Quick Ratio
6.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
14,792,000
Free Float
N/A
Market Cap
$124.84 million
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Samuel J. ReichMr. Samuel J. Reich (Age 46)
    CEO, CFO & Director

Key Competitors

View All Competitors













BCYP Stock - Frequently Asked Questions

How have BCYP shares performed in 2023?

Big Cypress Acquisition's stock was trading at $8.44 at the beginning of the year. Since then, BCYP stock has increased by 0.0% and is now trading at $8.44.
View the best growth stocks for 2023 here.

How were Big Cypress Acquisition's earnings last quarter?

Big Cypress Acquisition Corp. (OTCMKTS:BCYP) posted its quarterly earnings results on Tuesday, November, 11th. The technology company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). The technology company earned $0.31 million during the quarter, compared to analyst estimates of $0.21 million.

What other stocks do shareholders of Big Cypress Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Big Cypress Acquisition investors own include Co-Diagnostics (CODX), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL).

What is Big Cypress Acquisition's stock symbol?

Big Cypress Acquisition trades on the OTCMKTS under the ticker symbol "BCYP."

How do I buy shares of Big Cypress Acquisition?

Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Big Cypress Acquisition's stock price today?

One share of BCYP stock can currently be purchased for approximately $8.44.

How much money does Big Cypress Acquisition make?

Big Cypress Acquisition (OTCMKTS:BCYP) has a market capitalization of $124.84 million.

How can I contact Big Cypress Acquisition?

Big Cypress Acquisition's mailing address is 101 W. RENNER RD., RICHARDSON TX, 75082. The official website for the company is www.bluecalypso.com. The technology company can be reached via phone at 305-204-3338 or via email at investors@bluecalypso.com.

This page (OTCMKTS:BCYP) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -